{"id":"https://openalex.org/W4401010540","doi":"https://doi.org/10.1007/s40263-024-01105-z","title":"Caregiver Perspective of Benefits and Side Effects of Anti-Seizure Medications in CDKL5 Deficiency Disorder from an International Database","display_name":"Caregiver Perspective of Benefits and Side Effects of Anti-Seizure Medications in CDKL5 Deficiency Disorder from an International Database","publication_year":2024,"publication_date":"2024-07-26","ids":{"openalex":"https://openalex.org/W4401010540","doi":"https://doi.org/10.1007/s40263-024-01105-z","pmid":"https://pubmed.ncbi.nlm.nih.gov/39060900","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11316688"},"language":"en","primary_location":{"id":"doi:10.1007/s40263-024-01105-z","doi":"https://doi.org/10.1007/s40263-024-01105-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40263-024-01105-z","pdf_url":null,"source":{"id":"https://openalex.org/S153913659","display_name":"CNS Drugs","issn_l":"1172-7047","issn":["1172-7047","1179-1934"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1007/s40263-024-01105-z","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031126146","display_name":"Kingsley Wong","orcid":"https://orcid.org/0000-0001-5178-6080","observed_orcids":["https://orcid.org/0000-0001-5178-6080","https://orcid.org/0000-0001-9712-8585","https://orcid.org/0000-0002-1648-1414"]},"institutions":[{"id":"https://openalex.org/I175234967","display_name":"The Kids Research Institute Australia","ror":"https://ror.org/01dbmzx78","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I175234967"]},{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Kingsley Wong","raw_affiliation_strings":["Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, 15 Hospital Avenue, Nedlands, Perth, WA, 6009, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, 15 Hospital Avenue, Nedlands, Perth, WA, 6009, Australia","institution_ids":["https://openalex.org/I175234967","https://openalex.org/I177877127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080532140","display_name":"Mohammed A. Junaid","orcid":"https://orcid.org/0000-0002-2027-4231","observed_orcids":["https://orcid.org/0000-0002-2027-4231"]},"institutions":[{"id":"https://openalex.org/I175234967","display_name":"The Kids Research Institute Australia","ror":"https://ror.org/01dbmzx78","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I175234967"]},{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Mohammed Junaid","raw_affiliation_strings":["Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, 15 Hospital Avenue, Nedlands, Perth, WA, 6009, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, 15 Hospital Avenue, Nedlands, Perth, WA, 6009, Australia","institution_ids":["https://openalex.org/I175234967","https://openalex.org/I177877127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109753169","display_name":"Solomon Alexander","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I175234967","display_name":"The Kids Research Institute Australia","ror":"https://ror.org/01dbmzx78","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I175234967"]},{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Solomon Alexander","raw_affiliation_strings":["Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, 15 Hospital Avenue, Nedlands, Perth, WA, 6009, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, 15 Hospital Avenue, Nedlands, Perth, WA, 6009, Australia","institution_ids":["https://openalex.org/I175234967","https://openalex.org/I177877127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045426508","display_name":"Heather E. Olson","orcid":"https://orcid.org/0000-0002-5385-0119","observed_orcids":["https://orcid.org/0000-0002-5385-0119"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heather E. Olson","raw_affiliation_strings":["Division of Epilepsy and Clinical Neurophysiology and Epilepsy Genetics Program, Department of Neurology, Boston Children's Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Epilepsy and Clinical Neurophysiology and Epilepsy Genetics Program, Department of Neurology, Boston Children's Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1288882113"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050829954","display_name":"Elia Pestana\u2010Knight","orcid":"https://orcid.org/0000-0001-9068-4167","observed_orcids":["https://orcid.org/0000-0001-9068-4167"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elia M. Pestana-Knight","raw_affiliation_strings":["Cleveland Clinic, Neurological Institute, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic, Neurological Institute, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080018680","display_name":"Rajsekar R. Rajaraman","orcid":"https://orcid.org/0000-0002-9685-7118","observed_orcids":["https://orcid.org/0000-0002-9685-7118"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210134385","display_name":"Mattel Children's Hospital","ror":"https://ror.org/04p5baq95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I4210134385"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rajsekar R. Rajaraman","raw_affiliation_strings":["UCLA Mattel Children's Hospital, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA Mattel Children's Hospital, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I4210134385"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045593878","display_name":"Jenny Anne Downs","orcid":"https://orcid.org/0000-0001-7358-9037","observed_orcids":["https://orcid.org/0000-0001-7358-9037"]},"institutions":[{"id":"https://openalex.org/I175234967","display_name":"The Kids Research Institute Australia","ror":"https://ror.org/01dbmzx78","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I175234967"]},{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Jenny Downs","raw_affiliation_strings":["Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, 15 Hospital Avenue, Nedlands, Perth, WA, 6009, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, 15 Hospital Avenue, Nedlands, Perth, WA, 6009, Australia","institution_ids":["https://openalex.org/I175234967","https://openalex.org/I177877127"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062515759","display_name":"Helen Leonard","orcid":"https://orcid.org/0000-0001-6405-5834","observed_orcids":["https://orcid.org/0000-0001-6405-5834","https://orcid.org/0000-0002-3733-5678"]},"institutions":[{"id":"https://openalex.org/I175234967","display_name":"The Kids Research Institute Australia","ror":"https://ror.org/01dbmzx78","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I175234967"]},{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Helen Leonard","raw_affiliation_strings":["Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, 15 Hospital Avenue, Nedlands, Perth, WA, 6009, Australia. Helen.Leonard@telethonkids.org.au","Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, 15 Hospital Avenue, Nedlands, Perth, WA, 6009, Australia"],"raw_orcid":"https://orcid.org/0000-0001-6405-5834","affiliations":[{"raw_affiliation_string":"Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, 15 Hospital Avenue, Nedlands, Perth, WA, 6009, Australia. Helen.Leonard@telethonkids.org.au","institution_ids":["https://openalex.org/I175234967","https://openalex.org/I177877127"]},{"raw_affiliation_string":"Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, 15 Hospital Avenue, Nedlands, Perth, WA, 6009, Australia","institution_ids":["https://openalex.org/I175234967","https://openalex.org/I177877127"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5062515759"],"corresponding_institution_ids":["https://openalex.org/I175234967","https://openalex.org/I177877127"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":{"value":4790,"currency":"USD","value_usd":4790},"fwci":2.9749,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.92058391,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"38","issue":"9","first_page":"719","last_page":"732"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12049","display_name":"Tuberous Sclerosis Complex Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cdkl5-deficiency-disorder","display_name":"CDKL5 deficiency disorder","score":0.9980000257492065},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9800000190734863},{"id":"https://openalex.org/keywords/seizure-control","display_name":"seizure control","score":0.6549999713897705},{"id":"https://openalex.org/keywords/levetiracetam","display_name":"levetiracetam","score":0.8690000176429749},{"id":"https://openalex.org/keywords/topiramate","display_name":"topiramate","score":0.9670000076293945},{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":0.9800000190734863},{"id":"https://openalex.org/keywords/vigabatrin","display_name":"vigabatrin","score":0.9909999966621399},{"id":"https://openalex.org/keywords/phenobarbital","display_name":"phenobarbital","score":0.9950000047683716},{"id":"https://openalex.org/keywords/clobazam","display_name":"clobazam","score":0.9769999980926514},{"id":"https://openalex.org/keywords/cannabidiol","display_name":"cannabidiol","score":0.9509999752044678},{"id":"https://openalex.org/keywords/polypharmacy","display_name":"polypharmacy","score":0.8289999961853027},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.777999997138977},{"id":"https://openalex.org/keywords/refractory-seizures","display_name":"refractory seizures","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C103709681","wikidata":"https://www.wikidata.org/wiki/Q1515727","display_name":"Psychopharmacology","level":2,"score":0.7760370969772339},{"id":"https://openalex.org/C12713177","wikidata":"https://www.wikidata.org/wiki/Q1900281","display_name":"Perspective (graphical)","level":2,"score":0.6632390022277832},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.5988445281982422},{"id":"https://openalex.org/C16568411","wikidata":"https://www.wikidata.org/wiki/Q83042","display_name":"Neurology","level":2,"score":0.568442702293396},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5394599437713623},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46867069602012634},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4441075026988983},{"id":"https://openalex.org/C3454156","wikidata":"https://www.wikidata.org/wiki/Q1144241","display_name":"Side effect (computer science)","level":2,"score":0.42636731266975403},{"id":"https://openalex.org/C2994127763","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Antiepileptic drug","level":3,"score":0.4178541302680969},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000073376","descriptor_name":"Epileptic Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013036","descriptor_name":"Spasms, Infantile","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017028","descriptor_name":"Caregivers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1007/s40263-024-01105-z","doi":"https://doi.org/10.1007/s40263-024-01105-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40263-024-01105-z","pdf_url":null,"source":{"id":"https://openalex.org/S153913659","display_name":"CNS Drugs","issn_l":"1172-7047","issn":["1172-7047","1179-1934"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11316688","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11316688","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11316688/pdf/40263_2024_Article_1105.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"Text"},{"id":"pmid:39060900","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39060900","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS drugs","raw_type":"Journal Article"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt6c18t1h7","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/6c18t1h7","pdf_url":"https://escholarship.org/content/qt6c18t1h7/qt6c18t1h7.pdf","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"CNS Drugs, vol 38, iss 9","raw_type":"article"},{"id":"pmh:oai:pure.atira.dk:openaire/0a7365be-679e-4818-9e26-a0ccb1eebb56","doi":null,"is_oa":true,"landing_page_url":"https://www.scopus.com/pages/publications/85199516551","pdf_url":null,"source":{"id":"https://openalex.org/S4306402492","display_name":"UWA Profiles and Research Repository (UWA)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177877127","host_organization_name":"The University of Western Australia","host_organization_lineage":["https://openalex.org/I177877127"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Wong, K, Junaid, M, Alexander, S, Olson, H E, Pestana-Knight, E M, Rajaraman, R R, Downs, J & Leonard, H 2024, 'Caregiver Perspective of Benefits and Side Effects of Anti-Seizure Medications in CDKL5 Deficiency Disorder from an International Database', CNS Drugs, vol. 38, no. 9, pp. 719-732. https://doi.org/10.1007/s40263-024-01105-z","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1007/s40263-024-01105-z","doi":"https://doi.org/10.1007/s40263-024-01105-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40263-024-01105-z","pdf_url":null,"source":{"id":"https://openalex.org/S153913659","display_name":"CNS Drugs","issn_l":"1172-7047","issn":["1172-7047","1179-1934"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G1678884298","display_name":null,"funder_award_id":"CDKL5-19-D-101-3","funder_id":"https://openalex.org/F4320337958","funder_display_name":"Orphan Disease Center, Perelman School of Medicine, University of Pennsylvania"},{"id":"https://openalex.org/G9000863310","display_name":"Boston Children's Hospital/HMS Intellectual and Developmental Disabilities Research Center","funder_award_id":"P50HD105351","funder_id":"https://openalex.org/F4320337611","funder_display_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development"}],"funders":[{"id":"https://openalex.org/F1302897147","display_name":"Newron Pharmaceuticals","ror":"https://ror.org/05pwxq352"},{"id":"https://openalex.org/F4320310030","display_name":"Takeda Pharmaceuticals U.S.A.","ror":"https://ror.org/03bygaq51"},{"id":"https://openalex.org/F4320313767","display_name":"Zogenix","ror":"https://ror.org/03ynh3q24"},{"id":"https://openalex.org/F4320314124","display_name":"Ultragenyx Pharmaceutical","ror":"https://ror.org/00zbz2c25"},{"id":"https://openalex.org/F4320315029","display_name":"ACADIA Pharmaceuticals","ror":"https://ror.org/030bhbq32"},{"id":"https://openalex.org/F4320315433","display_name":"AveXis","ror":"https://ror.org/02gd4zp35"},{"id":"https://openalex.org/F4320316890","display_name":"Marinus Pharmaceuticals","ror":"https://ror.org/058sw7g55"},{"id":"https://openalex.org/F4320320991","display_name":"University of Western Australia","ror":"https://ror.org/047272k79"},{"id":"https://openalex.org/F4320326223","display_name":"International Foundation for CDKL5 Research","ror":"https://ror.org/05tqq9v14"},{"id":"https://openalex.org/F4320333071","display_name":"UCB US","ror":"https://ror.org/028qka468"},{"id":"https://openalex.org/F4320337611","display_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","ror":"https://ror.org/04byxyr05"},{"id":"https://openalex.org/F4320337958","display_name":"Orphan Disease Center, Perelman School of Medicine, University of Pennsylvania","ror":null},{"id":"https://openalex.org/F4815767975","display_name":"Taysha Gene Therapies","ror":"https://ror.org/0588nm138"},{"id":"https://openalex.org/F5205746475","display_name":"Orion Corporation","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4401010540.pdf","grobid_xml":"https://content.openalex.org/works/W4401010540.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W1662697425","https://openalex.org/W2011397887","https://openalex.org/W2020018978","https://openalex.org/W2062041648","https://openalex.org/W2076825430","https://openalex.org/W2156563690","https://openalex.org/W2338814967","https://openalex.org/W2509522099","https://openalex.org/W2537989343","https://openalex.org/W2626971719","https://openalex.org/W2846779511","https://openalex.org/W2883064449","https://openalex.org/W2916172020","https://openalex.org/W2921672021","https://openalex.org/W2958456424","https://openalex.org/W2961503558","https://openalex.org/W2969617720","https://openalex.org/W3024198750","https://openalex.org/W3092161933","https://openalex.org/W3103070654","https://openalex.org/W3107260325","https://openalex.org/W3120919740","https://openalex.org/W3154371553","https://openalex.org/W3176005071","https://openalex.org/W3200993708","https://openalex.org/W3205506387","https://openalex.org/W4223481134","https://openalex.org/W4224128253","https://openalex.org/W4224440073","https://openalex.org/W4281732229","https://openalex.org/W4283216555","https://openalex.org/W4292164125","https://openalex.org/W4295332390","https://openalex.org/W4300981509","https://openalex.org/W4367298009","https://openalex.org/W4388598339","https://openalex.org/W4392190872"],"related_works":["https://openalex.org/W4413015251","https://openalex.org/W3176005071","https://openalex.org/W3162981102","https://openalex.org/W2318339094","https://openalex.org/W3200993708","https://openalex.org/W6967052133","https://openalex.org/W2626971719","https://openalex.org/W7164151795","https://openalex.org/W2728123842","https://openalex.org/W4281732229"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"OBJECTIVE:":[2],"CDKL5":[3,45,54,69,180,301],"deficiency":[4,46,181,302],"disorder":[5],"presents":[6],"as":[7,210,347],"a":[8,19,76,85,244,269,283],"challenging":[9],"condition":[10],"with":[11,44,179,221,259,265],"early-onset":[12],"refractory":[13],"seizures,":[14],"severe":[15],"developmental":[16],"delays,":[17],"and":[18,32,82,84,91,107,119,139,144,150,177,188,208,227,239,323,349],"range":[20],"of":[21,35,94,130,142,167,191,250,273,290,297,309,320,343,353],"other":[22],"neurological":[23],"symptoms.":[24],"Our":[25,304],"study":[26,63,169,173,200,330],"aimed":[27],"to":[28,99,163,312,333],"explore":[29],"the":[30,52,67,110,113,117,120,137,157,165,168,185,211,294,307,318,324,334,340,350],"benefits":[31,135,187],"side":[33,146,189,223,262,275],"effects":[34,190,276],"anti-seizure":[36],"medications":[37,149],"(ASMs)":[38],"in":[39,255,300,356],"managing":[40],"seizures":[41],"among":[42],"individuals":[43,96],"disorder,":[47,182],"drawing":[48],"on":[49,102,196],"data":[50],"from":[51,66,75,156],"International":[53,68],"Disorder":[55,70],"Database.":[56],"METHODS:":[57],"Data":[58],"for":[59,124,136,326,336],"this":[60],"retrospective":[61],"cohort":[62],"were":[64,97,105,132,154,161],"obtained":[65],"Database,":[71],"which":[72],"contains":[73],"responses":[74],"baseline":[77],"questionnaire":[78,87],"administered":[79,88],"between":[80,89],"2012":[81],"2022":[83],"follow-up":[86],"2018":[90],"2019.":[92],"Families":[93],"eligible":[95],"asked":[98],"provide":[100],"information":[101],"ASMs":[103,143,153,194],"that":[104,287,289],"previously":[106],"currently":[108],"taken,":[109],"dose":[111],"prescribed,":[112],"age":[114,121],"at":[115,122],"starting":[116],"medications,":[118],"discontinuation":[123],"past":[125,140],"medications.":[126],"The":[127,172,199,280,329],"outcome":[128],"variables":[129],"interest":[131],"perceived":[133,186],"seizure-related":[134],"current":[138],"use":[141],"caregiver-reported":[145],"effects.":[147,263,328],"Rescue":[148],"infrequently":[151],"used":[152,162,213,243],"excluded":[155],"analysis.":[158],"Descriptive":[159],"statistics":[160],"summarise":[164],"characteristics":[166],"population.":[170],"RESULTS:":[171],"included":[174],"399":[175],"children":[176],"adults":[178],"descriptively":[183],"analysing":[184],"23":[192],"unique":[193],"based":[195],"caregiver":[197],"reports.":[198],"identified":[201],"levetiracetam,":[202],"topiramate,":[203],"sodium":[204,237],"valproate,":[205],"vigabatrin,":[206],"phenobarbital":[207,228],"clobazam":[209],"most":[212],"ASMs.":[214],"Notably,":[215],"cannabidiol":[216],"showed":[217],"highly":[218],"beneficial":[219],"outcomes":[220],"few":[222,261],"effects,":[224],"whereas":[225],"levetiracetam":[226,240],"exhibited":[229],"less":[230],"favourable":[231],"benefit-to-side-effect":[232],"ratios.":[233],"Dual":[234],"therapy":[235],"involving":[236],"valproate":[238],"was":[241],"only":[242],"small":[245],"number":[246],"(n":[247],"=":[248],"5)":[249],"times":[251],"but":[252],"appeared":[253],"effective":[254],"reducing":[256],"seizure":[257,298,321,357],"activity":[258],"relatively":[260,270],"Compared":[264],"monotherapy,":[266],"polytherapy":[267],"had":[268],"higher":[271],"likelihood":[272],"reported":[274],"than":[277],"benefits.":[278],"CONCLUSIONS:":[279],"study,":[281],"leveraging":[282],"large":[284],"sample":[285],"size":[286],"exceeds":[288],"previous":[291],"research,":[292],"emphasises":[293],"complex":[295],"nature":[296],"management":[299],"disorder.":[303],"findings":[305],"underscore":[306],"necessity":[308],"ongoing":[310],"research":[311],"optimise":[313],"treatment":[314],"strategies,":[315],"considering":[316],"both":[317],"efficacy":[319,352],"control":[322],"potential":[325,342],"adverse":[327],"also":[331],"points":[332],"need":[335],"future":[337],"investigations":[338],"into":[339],"therapeutic":[341],"emerging":[344],"treatments":[345],"such":[346],"ganaxolone":[348],"unresolved":[351],"cannabis":[354],"products":[355],"management.":[358]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-07-27T00:00:00"}